OCULIS

oculis-logo

The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. Furthermore, the technique has been demonstrated to allow diseases at the anterior part of the eye to be treated with a reduced number of topical applications compared to conventional eye-drops.

#SimilarOrganizations #People #Financial #Event #Website #More

OCULIS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2003-01-01

Address:
Reykjavík, Gullbringusysla, Iceland

Country:
Iceland

Website Url:
http://www.oculis.com

Total Employee:
11+

Status:
Active

Contact:
+354 546-4440

Email Addresses:
[email protected]

Total Funding:
94.36 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Apache


Similar Organizations

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

immutep-logo

Immutep

Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.


Current Advisors List

anthony-rosenberg_image

Anthony Rosenberg Board Member @ Oculis
Board_member

bart-dzikowski_image

Bart Dzikowski Board Member @ Oculis
Board_member
2019-05-01

lionel-carnot_image

Lionel Carnot Board Member @ Oculis
Board_member
2017-12-01

arni-blöndal_image

Arni Blöndal Board Member @ Oculis
Board_member
2016-08-01

not_available_image

Sylvia He Board of Directors @ Oculis
Board_member
2021-05-04

riad-sherif_image

Riad Sherif Board Member @ Oculis
Board_member

rob-hopfner_image

Rob Hopfner Board Member @ Oculis
Board_member

not_available_image

Vanessa Huang Board of Directors @ Oculis
Board_member
2021-05-04

Current Employees Featured

einar-stefansson_image

Einar Stefansson
Einar Stefansson Chief Medical Officer & Co-Founder @ Oculis
Chief Medical Officer & Co-Founder
2004-02-01

not_available_image

Páll Ragnar Jóhannesson
Páll Ragnar Jóhannesson Chief Executive Officer @ Oculis
Chief Executive Officer

riad-sherif_image

Riad SHERIF
Riad SHERIF CEO @ Oculis
CEO
2017-11-01

sylvia-cheung_image

Sylvia Cheung
Sylvia Cheung Chief Financial Officer @ Oculis
Chief Financial Officer
2020-09-01

thorsteinn-loftsson_image

Thorsteinn Loftsson
Thorsteinn Loftsson Chief Scientific Officer @ Oculis
Chief Scientific Officer

marcia-de-souza-lima_image

Marcia de Souza Lima
Marcia de Souza Lima Chief Medical Officer @ Oculis
Chief Medical Officer
2020-02-01

gudrun-marta-asgrimsdottir_image

Gudrun Marta Asgrimsdottir
Gudrun Marta Asgrimsdottir VP, Pharmaceutical Development @ Oculis
VP, Pharmaceutical Development
2010-08-01

not_available_image

Bastian Dehmel
Bastian Dehmel Chief Development Officer @ Oculis
Chief Development Officer
2022-01-01

david-p-bingaman_image

David P. Bingaman
David P. Bingaman Vice President , Head & Global Clinical Development @ Oculis
Vice President , Head & Global Clinical Development
2020-06-01

frédéric-pilotaz_image

Frédéric Pilotaz
Frédéric Pilotaz VP, Technology & Pharmaceutical Sciences @ Oculis
VP, Technology & Pharmaceutical Sciences
2020-03-01

Founder


einar-stefansson_image

Einar Stefansson

thorsteinn-loftsson_image

Thorsteinn Loftsson

Investors List

hyfinity-investments_image

Hyfinity Investments

Hyfinity Investments investment in Series C - Oculis

bay-city-capital_image

Bay City Capital

Bay City Capital investment in Series C - Oculis

nan-fung-life-sciences_image

Nan Fung Life Sciences

Nan Fung Life Sciences investment in Series C - Oculis

bioveda-china-fund_image

BVCF

BVCF investment in Series C - Oculis

tekla-capital-management_image

Tekla Capital Management

Tekla Capital Management investment in Series C - Oculis

silfurberg_image

Silfurberg

Silfurberg investment in Series C - Oculis

venture-capital-fund-brunnur_image

Brunnur Ventures

Brunnur Ventures investment in Series C - Oculis

pivotal-bioventure-partners_image

Pivotal bioVenture Partners

Pivotal bioVenture Partners investment in Series C - Oculis

vi-partners_image

VI Partners

VI Partners investment in Series C - Oculis

novartis-venture-fund_image

Novartis Venture Fund

Novartis Venture Fund investment in Series C - Oculis

Official Site Inspections

http://www.oculis.com Semrush global rank: 3.27 M Semrush visits lastest month: 5.03 K

  • Host name: 141.193.213.11
  • IP address: 141.193.213.11
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Oculis" on Search Engine